About Biogen Canada

Proudly serving Canadians since 1998

Biogen Canada has been proudly serving Canadians since its establishment in Mississauga, Ontario in April 1998. We have an incredibly talented team who cares deeply and works fearlessly day in, day out to make a difference and change lives. Our team’s pioneering spirit and firm commitment to patients with complex diseases fuels our drive to innovate and help Canadians access ground-breaking treatments and services that can transform health, well-being, and quality of life.

A rich Canadian legacy

We are trusted leaders in the fields of multiple sclerosis (MS) and spinal muscular atrophy (SMA) and continue to make advances for patients in these communities. We are also deepening our commitment to new therapy areas like Alzheimer’s disease (AD) and amyotrophic lateral sclerosis (ALS), while our investment in biosimilars aims to further support Canadians and the sustainability of healthcare systems by enhancing patient access to advanced, cost-effective therapies.

Supporting patients beyond therapy

Our best-in-class digital and one-on-one support programs help guide and empower patients through their treatment and care journeys with personalized resources and education about their health and system navigation. 

>35K Canadians have been treated with a Biogen medicine.

Strong investment in Canadian R&D

We are a proud partner in the healthcare system, investing in innovation and advocacy that helps accelerate equitable patient access to new, life-changing treatments and services. Canada holds some of the top academic institutions in the world, with renowned researchers who have been part of major clinical breakthroughs to advance science and bring treatments to areas with significant unmet need. We have Canadian studies in eight disease areas, including Alzheimer’s, ALS, lupus, MS, neuropsychiatry, Parkinson's disease, SMA and stroke. We are proud to be an industry leader who invests heavily into Canadian research, development, and product innovation - more than 150 million Canadian dollars over the past five years. 


Percentage of Canadian sales invested in R&D over the past five years.

Our people

At Biogen we care deeply, a commitment reflected in our devotion to both the patients we serve as well as our people. Our team brings unmatched determination and ambition to the work we do; together, we achieve the extraordinary. Recognized as a Great Place to Work®, Biogen takes great pride in celebrating employees from all walks of life – their diversity enriches our team and we are committed to providing an open and inclusive work environment where all are free to be their true selves.

Facts and Figures


Years in Canada


Great Place to Work® recognition awards.


Women in Canadian Leadership Team

Biogen Canada Recognized as A Great Place To Work®